The presence of inexpensive centers and new data collection tools show promise in cutting costs as providers take a new path in care delivery, says Eric Topol, MD, Director of the Scripps Translational Science Institute, Chief Academic Officer at Scripps Health, Cardiologist, and Professor of Genomics at The Scripps Research Institute.
The presence of inexpensive centers and new data collection tools show promise in cutting costs as providers take a new path in care delivery, saids Eric Topol, MD, Director of the Scripps Translational Science Institute, Chief Academic Officer at Scripps Health, Cardiologist, and Professor of Genomics at The Scripps Research Institute. “For example, why would you have a sleep study done in a hospital setting when you could do this in the convenience and lack of expense in one’s own home?” asked Dr. Topol. Additionally, Dr. Topol suggests that new technologies will allow consumers to control their own health information while improving their overall quality of care. He says an individual will be able to review their data in a very simplified way. For instance, a smart phone could directly provide important information to the consumer.
Using AI for the Medical Note: Game Changer or a Bridge Too Far?
July 9th 2025During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial intelligence (AI) tools like DeepScribe to enhance documentation efficiency, reduce burnout, and improve patient engagement in clinical settings.
Read More
Practical Considerations for AI in Community Oncology
July 8th 2025Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Read More
How AI Can Address the Troubled Business Model in Oncology
July 7th 2025Artificial intelligence (AI) will transform community oncology, addressing workforce shortages and reimbursement challenges while enhancing patient care and operational efficiency, discussed speakers at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
At ASCO, Testing and AI Rival Drugs for Attention, but Reimbursement Remains a Barrier
July 5th 2025Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage cancer care over time. A feature from our upcoming special issue of Evidence-Based Oncology: our annual ASCO recap.
Read More